| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 3.44e-06 | 27 | 80 | 4 | GO:0032331 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 6.95e-06 | 32 | 80 | 4 | GO:0035162 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 1.12e-05 | 36 | 80 | 4 | GO:0061037 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast fusion | 5.21e-05 | 19 | 80 | 3 | GO:1901741 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | ADAMTS12 FBN1 EFEMP1 NF1 NFATC2 ADAMTS7 ING1 ADAMTS9 ADGRB1 SAV1 LRP4 LTBP3 ZFPM1 EZH2 LDLR | 6.11e-05 | 1220 | 80 | 15 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 8.12e-05 | 59 | 80 | 4 | GO:0032330 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 8.87e-05 | 4 | 80 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 8.87e-05 | 4 | 80 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | regulation of myoblast fusion | 1.22e-04 | 25 | 80 | 3 | GO:1901739 | |
| GeneOntologyBiologicalProcess | positive regulation of syncytium formation by plasma membrane fusion | 1.54e-04 | 27 | 80 | 3 | GO:0060143 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | ADAMTS12 FBN1 EFEMP1 NF1 ADAMTS7 ING1 ADAMTS9 ADGRB1 SAV1 LRP4 LTBP3 ZFPM1 EZH2 LDLR TRIM5 SVEP1 | 1.62e-04 | 1488 | 80 | 16 | GO:0051241 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.18e-04 | 76 | 80 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 2.78e-04 | 81 | 80 | 4 | GO:0061035 | |
| GeneOntologyBiologicalProcess | regulation of syncytium formation by plasma membrane fusion | 3.66e-04 | 36 | 80 | 3 | GO:0060142 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.10e-04 | 8 | 80 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | tricuspid valve morphogenesis | 4.10e-04 | 8 | 80 | 2 | GO:0003186 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 4.10e-04 | 8 | 80 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | primitive erythrocyte differentiation | 4.10e-04 | 8 | 80 | 2 | GO:0060319 | |
| GeneOntologyBiologicalProcess | myotube differentiation | 4.44e-04 | 164 | 80 | 5 | GO:0014902 | |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 ADAMTS19 FBN1 FCGBP FBN2 EFEMP1 HMCN1 ADAMTS7 ADAMTS9 LTBP3 PKHD1L1 SVEP1 | 8.31e-06 | 658 | 81 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 ADAMTS19 FBN1 FCGBP FBN2 EFEMP1 HMCN1 ADAMTS7 ADAMTS9 LTBP3 SVEP1 | 4.41e-05 | 656 | 81 | 11 | GO:0031012 |
| HumanPheno | Fifth metacarpal with ulnar notch | 3.58e-05 | 2 | 31 | 2 | HP:0005900 | |
| HumanPheno | Gastric diverticulum | 3.58e-05 | 2 | 31 | 2 | HP:0100808 | |
| Domain | EGF_Ca-bd_CS | 4.04e-10 | 97 | 82 | 9 | IPR018097 | |
| Domain | EGF_CA | 4.86e-10 | 99 | 82 | 9 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.32e-10 | 100 | 82 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.99e-10 | 106 | 82 | 9 | IPR000152 | |
| Domain | cEGF | 1.28e-09 | 26 | 82 | 6 | IPR026823 | |
| Domain | cEGF | 1.28e-09 | 26 | 82 | 6 | PF12662 | |
| Domain | EGF_CA | 3.15e-09 | 122 | 82 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.64e-09 | 124 | 82 | 9 | IPR001881 | |
| Domain | EGF_CA | 3.92e-09 | 86 | 82 | 8 | PF07645 | |
| Domain | Growth_fac_rcpt_ | 2.73e-08 | 156 | 82 | 9 | IPR009030 | |
| Domain | EGF | 7.96e-08 | 235 | 82 | 10 | SM00181 | |
| Domain | EGF-like_dom | 1.37e-07 | 249 | 82 | 10 | IPR000742 | |
| Domain | EGF_1 | 1.70e-07 | 255 | 82 | 10 | PS00022 | |
| Domain | EGF_2 | 2.43e-07 | 265 | 82 | 10 | PS01186 | |
| Domain | TSP_1 | 3.31e-07 | 63 | 82 | 6 | PF00090 | |
| Domain | TSP1 | 4.00e-07 | 65 | 82 | 6 | SM00209 | |
| Domain | TSP1_rpt | 4.00e-07 | 65 | 82 | 6 | IPR000884 | |
| Domain | TSP1 | 4.00e-07 | 65 | 82 | 6 | PS50092 | |
| Domain | EGF_3 | 8.95e-07 | 235 | 82 | 9 | PS50026 | |
| Domain | EGF-like_CS | 2.13e-06 | 261 | 82 | 9 | IPR013032 | |
| Domain | TB | 2.82e-06 | 7 | 82 | 3 | PF00683 | |
| Domain | ADAM_spacer1 | 2.87e-06 | 23 | 82 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.87e-06 | 23 | 82 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.43e-06 | 24 | 82 | 4 | IPR013273 | |
| Domain | - | 4.50e-06 | 8 | 82 | 3 | 3.90.290.10 | |
| Domain | hEGF | 6.52e-06 | 28 | 82 | 4 | PF12661 | |
| Domain | TB | 6.72e-06 | 9 | 82 | 3 | PS51364 | |
| Domain | TB_dom | 6.72e-06 | 9 | 82 | 3 | IPR017878 | |
| Domain | Peptidase_M12B_N | 2.53e-05 | 39 | 82 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.53e-05 | 39 | 82 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.80e-05 | 40 | 82 | 4 | PS00427 | |
| Domain | Reprolysin | 2.80e-05 | 40 | 82 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 2.80e-05 | 40 | 82 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.80e-05 | 40 | 82 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 2.80e-05 | 40 | 82 | 4 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 3.09e-05 | 41 | 82 | 4 | PS00546 | |
| Domain | Disintegrin_dom | 3.09e-05 | 41 | 82 | 4 | IPR001762 | |
| Domain | Znf_RING/FYVE/PHD | 3.21e-05 | 459 | 82 | 10 | IPR013083 | |
| Domain | Pept_M10_metallopeptidase | 3.74e-05 | 43 | 82 | 4 | IPR001818 | |
| Domain | FBN | 5.70e-05 | 3 | 82 | 2 | IPR011398 | |
| Domain | PLAC | 7.51e-05 | 19 | 82 | 3 | PS50900 | |
| Domain | PLAC | 7.51e-05 | 19 | 82 | 3 | IPR010909 | |
| Domain | - | 1.54e-04 | 449 | 82 | 9 | 3.30.40.10 | |
| Domain | FYrich_C | 1.89e-04 | 5 | 82 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.89e-04 | 5 | 82 | 2 | IPR003888 | |
| Domain | FYRC | 1.89e-04 | 5 | 82 | 2 | SM00542 | |
| Domain | FYRN | 1.89e-04 | 5 | 82 | 2 | SM00541 | |
| Domain | FYRN | 1.89e-04 | 5 | 82 | 2 | PF05964 | |
| Domain | FYRC | 1.89e-04 | 5 | 82 | 2 | PF05965 | |
| Domain | FYRC | 1.89e-04 | 5 | 82 | 2 | PS51543 | |
| Domain | FYRN | 1.89e-04 | 5 | 82 | 2 | PS51542 | |
| Domain | ZF_RING_1 | 2.91e-04 | 291 | 82 | 7 | PS00518 | |
| Domain | TIG | 3.36e-04 | 31 | 82 | 3 | PF01833 | |
| Domain | ZF_RING_2 | 3.36e-04 | 298 | 82 | 7 | PS50089 | |
| Domain | IPT | 3.69e-04 | 32 | 82 | 3 | IPR002909 | |
| Domain | ZF_UBR | 3.94e-04 | 7 | 82 | 2 | PS51157 | |
| Domain | zf-UBR | 3.94e-04 | 7 | 82 | 2 | PF02207 | |
| Domain | Znf_UBR | 3.94e-04 | 7 | 82 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 3.94e-04 | 7 | 82 | 2 | SM00396 | |
| Domain | MetalloPept_cat_dom | 4.44e-04 | 81 | 82 | 4 | IPR024079 | |
| Domain | - | 4.44e-04 | 81 | 82 | 4 | 3.40.390.10 | |
| Domain | Znf_RING | 5.74e-04 | 326 | 82 | 7 | IPR001841 | |
| Domain | SET | 7.71e-04 | 41 | 82 | 3 | PF00856 | |
| Domain | ZF_PHD_1 | 8.44e-04 | 96 | 82 | 4 | PS01359 | |
| Domain | ZINC_PROTEASE | 9.11e-04 | 98 | 82 | 4 | PS00142 | |
| Domain | - | 1.02e-03 | 11 | 82 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.02e-03 | 11 | 82 | 2 | IPR023413 | |
| Domain | SET | 1.08e-03 | 46 | 82 | 3 | SM00317 | |
| Domain | Ig_E-set | 1.14e-03 | 104 | 82 | 4 | IPR014756 | |
| Domain | SET_dom | 1.38e-03 | 50 | 82 | 3 | IPR001214 | |
| Domain | SET | 1.38e-03 | 50 | 82 | 3 | PS50280 | |
| Domain | Ldl_recept_b | 1.67e-03 | 14 | 82 | 2 | PF00058 | |
| Domain | LDLRB | 1.67e-03 | 14 | 82 | 2 | PS51120 | |
| Domain | LY | 1.93e-03 | 15 | 82 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.93e-03 | 15 | 82 | 2 | IPR000033 | |
| Domain | Post-SET_dom | 2.20e-03 | 16 | 82 | 2 | IPR003616 | |
| Domain | PostSET | 2.20e-03 | 16 | 82 | 2 | SM00508 | |
| Domain | POST_SET | 2.20e-03 | 16 | 82 | 2 | PS50868 | |
| Domain | RING | 2.24e-03 | 305 | 82 | 6 | SM00184 | |
| Domain | EGF | 2.30e-03 | 126 | 82 | 4 | PF00008 | |
| Domain | zf-C3HC4 | 3.00e-03 | 223 | 82 | 5 | PF00097 | |
| Domain | CONNEXINS_1 | 3.10e-03 | 19 | 82 | 2 | PS00407 | |
| Domain | CONNEXINS_2 | 3.44e-03 | 20 | 82 | 2 | PS00408 | |
| Domain | Connexin | 3.44e-03 | 20 | 82 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 3.44e-03 | 20 | 82 | 2 | IPR019570 | |
| Domain | Connexin_N | 3.44e-03 | 20 | 82 | 2 | IPR013092 | |
| Domain | Connexin | 3.44e-03 | 20 | 82 | 2 | PF00029 | |
| Domain | Connexin_CCC | 3.44e-03 | 20 | 82 | 2 | SM01089 | |
| Domain | Connexin_CS | 3.44e-03 | 20 | 82 | 2 | IPR017990 | |
| Domain | CNX | 3.44e-03 | 20 | 82 | 2 | SM00037 | |
| Domain | Znf_FYVE_PHD | 4.01e-03 | 147 | 82 | 4 | IPR011011 | |
| Domain | EPHD | 4.15e-03 | 22 | 82 | 2 | PS51805 | |
| Domain | PHD | 4.39e-03 | 75 | 82 | 3 | PF00628 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.19e-06 | 37 | 51 | 4 | M27134 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.14e-05 | 39 | 51 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.14e-05 | 39 | 51 | 4 | MM15165 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.85e-05 | 44 | 51 | 4 | M26969 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.04e-04 | 68 | 51 | 4 | M27303 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.05e-04 | 32 | 51 | 3 | MM14854 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.44e-04 | 38 | 51 | 3 | MM17073 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.54e-04 | 8 | 51 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.72e-04 | 39 | 51 | 3 | MM14601 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 4.64e-04 | 42 | 51 | 3 | M48018 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.32e-04 | 44 | 51 | 3 | MM15527 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 6.07e-04 | 46 | 51 | 3 | MM14933 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.39e-04 | 109 | 51 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.84e-04 | 111 | 51 | 4 | M27416 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.11e-04 | 300 | 51 | 6 | M610 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 1.14e-03 | 14 | 51 | 2 | M47834 | |
| Pubmed | 2.52e-08 | 75 | 82 | 6 | 20637190 | ||
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 5.04e-08 | 4 | 82 | 3 | 25406291 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TYK2 KMT2D ZNF628 ADAMTS7 PIEZO1 ZNF408 UBR4 TMEM268 LRP4 LTBP3 ZFPM1 LDLR RNF43 TOP3A | 2.89e-07 | 1105 | 82 | 14 | 35748872 |
| Pubmed | 7.42e-07 | 71 | 82 | 5 | 33541421 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX22 BCL6B GSX1 KMT2D ZBTB17 NFATC2 KMT2A PLAGL2 ZFPM1 CAMTA1 EZH2 LHX6 | 1.45e-06 | 908 | 82 | 12 | 19274049 |
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 11167130 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.74e-06 | 12 | 82 | 3 | 25770910 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12399449 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21851253 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 5.49e-06 | 2 | 82 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 5.49e-06 | 2 | 82 | 2 | 26494287 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 5.49e-06 | 2 | 82 | 2 | 21440062 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 5.49e-06 | 2 | 82 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 5.49e-06 | 2 | 82 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 5.49e-06 | 2 | 82 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 5.49e-06 | 2 | 82 | 2 | 7744963 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 5.49e-06 | 2 | 82 | 2 | 18006876 | |
| Pubmed | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | 5.49e-06 | 2 | 82 | 2 | 19098927 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 35032074 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 5.49e-06 | 2 | 82 | 2 | 24833718 | |
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 5.49e-06 | 2 | 82 | 2 | 26711341 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24265020 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20529844 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24423662 | ||
| Pubmed | MLL1:EZH2 Ratio in Uterine Secretions and Endometrial Receptivity in Patients with Endometriosis. | 5.49e-06 | 2 | 82 | 2 | 36094360 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 23133647 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 30306291 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 5.49e-06 | 2 | 82 | 2 | 1852206 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12429739 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 5.49e-06 | 2 | 82 | 2 | 12524050 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 5.49e-06 | 2 | 82 | 2 | 29625025 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 8120105 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 5.49e-06 | 2 | 82 | 2 | 10504303 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29515022 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 5.49e-06 | 2 | 82 | 2 | 25524144 | |
| Pubmed | An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells. | 5.49e-06 | 2 | 82 | 2 | 30710146 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 5.49e-06 | 2 | 82 | 2 | 16407178 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10359653 | ||
| Pubmed | Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. | 5.49e-06 | 2 | 82 | 2 | 22247065 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.00e-05 | 18 | 82 | 3 | 35503090 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 10825173 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31431463 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 30201140 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 26902498 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23932714 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 38757931 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20301776 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20855508 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 25712206 | ||
| Pubmed | Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice. | 1.64e-05 | 3 | 82 | 2 | 24551105 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31582835 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23192982 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 26431491 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 33340495 | ||
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 1.64e-05 | 3 | 82 | 2 | 30315824 | |
| Pubmed | The Polycomb-Dependent Epigenome Controls β Cell Dysfunction, Dedifferentiation, and Diabetes. | 3.28e-05 | 4 | 82 | 2 | 29754954 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 22863532 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20154697 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20729550 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 32123116 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.28e-05 | 4 | 82 | 2 | 25034023 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 37722486 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 12429738 | ||
| Pubmed | Polycomb repressive complex 2 is required for MLL-AF9 leukemia. | 3.28e-05 | 4 | 82 | 2 | 22396593 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 16835936 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 3.28e-05 | 4 | 82 | 2 | 23129768 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 34564701 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 18485748 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 24081332 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 26601954 | ||
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 5.47e-05 | 5 | 82 | 2 | 28609655 | |
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 5.47e-05 | 5 | 82 | 2 | 23493297 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 26320581 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 12590922 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 17255108 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 34411563 | ||
| Pubmed | TYK2 FBN2 ATXN7L2 TRIP6 ARRDC4 LRP4 CRYBG3 LDLR RNF43 C2CD5 WDTC1 | 6.17e-05 | 1116 | 82 | 11 | 31753913 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.70e-05 | 184 | 82 | 5 | 32908313 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 34933446 | ||
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 8.19e-05 | 6 | 82 | 2 | 16199523 | |
| Pubmed | PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes. | 8.19e-05 | 6 | 82 | 2 | 30089852 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 7873879 | ||
| Pubmed | Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. | 8.19e-05 | 6 | 82 | 2 | 24176642 | |
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 19219072 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 36598580 | ||
| Pubmed | Regulation of limb patterning by extracellular microfibrils. | 1.14e-04 | 7 | 82 | 2 | 11470817 | |
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 21135039 | ||
| Pubmed | 1.23e-04 | 469 | 82 | 7 | 27634302 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 1.52e-04 | 8 | 82 | 2 | 23055981 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 1.52e-04 | 8 | 82 | 2 | 31201465 | |
| Pubmed | Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation. | 1.52e-04 | 8 | 82 | 2 | 30482854 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 23853098 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 22266653 | ||
| Pubmed | Divergent hTAFII31-binding motifs hidden in activation domains. | 1.52e-04 | 8 | 82 | 2 | 10821850 | |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 1.52e-04 | 8 | 82 | 2 | 22722839 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.52e-04 | 8 | 82 | 2 | 23130995 | |
| Pubmed | Targeting of bone morphogenetic protein growth factor complexes to fibrillin. | 1.52e-04 | 8 | 82 | 2 | 18339631 | |
| Interaction | NTN5 interactions | 3.70e-08 | 24 | 81 | 5 | int:NTN5 | |
| Interaction | ZNF408 interactions | 1.92e-06 | 145 | 81 | 7 | int:ZNF408 | |
| Interaction | FBN2 interactions | 6.33e-06 | 65 | 81 | 5 | int:FBN2 | |
| Interaction | LTBP1 interactions | 3.46e-05 | 92 | 81 | 5 | int:LTBP1 | |
| Cytoband | 1p36.13 | 1.42e-04 | 56 | 82 | 3 | 1p36.13 | |
| Cytoband | 11p11.2 | 4.55e-04 | 83 | 82 | 3 | 11p11.2 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.99e-07 | 19 | 63 | 4 | 50 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.23e-04 | 34 | 63 | 3 | 487 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 2.48e-04 | 7 | 63 | 2 | 785 | |
| GeneFamily | PHD finger proteins | 2.73e-04 | 90 | 63 | 4 | 88 | |
| GeneFamily | Fibulins | 3.30e-04 | 8 | 63 | 2 | 556 | |
| GeneFamily | Low density lipoprotein receptors | 9.09e-04 | 13 | 63 | 2 | 634 | |
| GeneFamily | Gap junction proteins | 2.64e-03 | 22 | 63 | 2 | 314 | |
| GeneFamily | Ring finger proteins | 2.69e-03 | 275 | 63 | 5 | 58 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.35e-03 | 718 | 63 | 8 | 28 | |
| GeneFamily | Tudor domain containing | 7.36e-03 | 37 | 63 | 2 | 780 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.16e-06 | 191 | 81 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.56e-06 | 196 | 81 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 2.07e-05 | 270 | 81 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.32e-05 | 275 | 81 | 7 | M5884 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | 3.46e-05 | 402 | 81 | 8 | M45754 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 3.49e-05 | 198 | 81 | 6 | M6511 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 ADAMTS19 FLT3LG FBN1 FBN2 EFEMP1 HMCN1 ADAMTS7 ADAMTS9 NTN5 LTBP3 SVEP1 | 6.01e-05 | 1008 | 81 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS12 ADAMTS19 FLT3LG FBN1 FBN2 EFEMP1 HMCN1 ADAMTS7 ADAMTS9 NTN5 LTBP3 SVEP1 | 7.12e-05 | 1026 | 81 | 12 | M5889 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 160 | 82 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 160 | 82 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-06 | 197 | 82 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 165 | 82 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 165 | 82 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.12e-05 | 181 | 82 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 184 | 82 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.54e-05 | 188 | 82 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 188 | 82 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 188 | 82 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 188 | 82 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-05 | 189 | 82 | 5 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.74e-05 | 191 | 82 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.88e-05 | 193 | 82 | 5 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 193 | 82 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.88e-05 | 193 | 82 | 5 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.95e-05 | 194 | 82 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 194 | 82 | 5 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-05 | 195 | 82 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-05 | 195 | 82 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.18e-05 | 197 | 82 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 197 | 82 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 197 | 82 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.18e-05 | 197 | 82 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.18e-05 | 197 | 82 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-05 | 199 | 82 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 199 | 82 | 5 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | cd381644fd8b8674a017d267bfbb00f2668294ae | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-05 | 200 | 82 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-04 | 139 | 82 | 4 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Adcy1_(Reticular_formation)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.43e-04 | 55 | 82 | 3 | a911a29c2db5bf32a209a9c01afc96c9f8b401f6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Adcy1_(Reticular_formation)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.43e-04 | 55 | 82 | 3 | cff015b3803f5c06afc8b22be057322e0dcbd4f2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 144 | 82 | 4 | cf9f049ab6cd80521598124f057c2debdde24788 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 144 | 82 | 4 | 41eaeca54b3c39de417597267cbdb1f195dd885a | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_TCM|Bac-SEP / Disease, Lineage and Cell Type | 1.61e-04 | 148 | 82 | 4 | 5814bfb5060bac455334eb50d2a7b1f01c0b6831 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 148 | 82 | 4 | 065177aaa63c0441d312260b43ecdac78c84ad03 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.74e-04 | 151 | 82 | 4 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 156 | 82 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.12e-04 | 159 | 82 | 4 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.12e-04 | 159 | 82 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 2.12e-04 | 159 | 82 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-04 | 159 | 82 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.12e-04 | 159 | 82 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 160 | 82 | 4 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 160 | 82 | 4 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 162 | 82 | 4 | 075f73ff10e1a7f5695e014e47acc4db513e9cfb | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 162 | 82 | 4 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-04 | 164 | 82 | 4 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.39e-04 | 164 | 82 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 2.44e-04 | 165 | 82 | 4 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-04 | 165 | 82 | 4 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 168 | 82 | 4 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.61e-04 | 168 | 82 | 4 | 273168eefe0dae5494ac6ff5306bb307f06dc9c5 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 168 | 82 | 4 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 168 | 82 | 4 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-04 | 169 | 82 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.67e-04 | 169 | 82 | 4 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.67e-04 | 169 | 82 | 4 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.74e-04 | 170 | 82 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 171 | 82 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 171 | 82 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 171 | 82 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 172 | 82 | 4 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 175 | 82 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 175 | 82 | 4 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 176 | 82 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 176 | 82 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 176 | 82 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 176 | 82 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.19e-04 | 177 | 82 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.19e-04 | 177 | 82 | 4 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.26e-04 | 178 | 82 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.33e-04 | 179 | 82 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-04 | 179 | 82 | 4 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 180 | 82 | 4 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 180 | 82 | 4 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 180 | 82 | 4 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.47e-04 | 181 | 82 | 4 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-04 | 181 | 82 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-04 | 182 | 82 | 4 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-04 | 182 | 82 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.54e-04 | 182 | 82 | 4 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 183 | 82 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-04 | 183 | 82 | 4 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-04 | 184 | 82 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-04 | 184 | 82 | 4 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 6.93e-06 | 196 | 82 | 7 | 3572_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 7344_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | glioblastoma (is_implicated_in) | 3.46e-05 | 24 | 78 | 3 | DOID:3068 (is_implicated_in) | |
| Disease | scoliosis (is_implicated_in) | 4.12e-05 | 4 | 78 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 6.86e-05 | 5 | 78 | 2 | C3489726 | |
| Disease | Weaver syndrome | 6.86e-05 | 5 | 78 | 2 | C0265210 | |
| Disease | Acromicric Dysplasia | 6.86e-05 | 5 | 78 | 2 | C0265287 | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 1.03e-04 | 6 | 78 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | myelofibrosis (is_implicated_in) | 1.91e-04 | 8 | 78 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | Microphthalmos | 3.74e-04 | 11 | 78 | 2 | C0026010 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.74e-04 | 11 | 78 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Endometrial Neoplasms | 4.94e-04 | 58 | 78 | 3 | C0014170 | |
| Disease | colon cancer (is_marker_for) | 5.19e-04 | 59 | 78 | 3 | DOID:219 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 5.56e-04 | 142 | 78 | 4 | DOID:10534 (is_marker_for) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 6.30e-04 | 63 | 78 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | cortical thickness | FBN1 FBN2 ADAMTS7 ADAMTS9 FZD3 ARRDC4 LRP4 KMT2A CAMTA1 CLUH | 6.88e-04 | 1113 | 78 | 10 | EFO_0004840 |
| Disease | Lymphoma, Large-Cell, Follicular | 7.08e-04 | 15 | 78 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 7.08e-04 | 15 | 78 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 7.08e-04 | 15 | 78 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 7.08e-04 | 15 | 78 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 7.08e-04 | 15 | 78 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 7.08e-04 | 15 | 78 | 2 | C1956130 | |
| Disease | uterine prolapse | 8.08e-04 | 16 | 78 | 2 | EFO_1001864 | |
| Disease | Endometrial Carcinoma | 9.29e-04 | 72 | 78 | 3 | C0476089 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.09e-03 | 293 | 78 | 5 | C1708349 | |
| Disease | Juvenile Myelomonocytic Leukemia | 1.15e-03 | 19 | 78 | 2 | C0349639 | |
| Disease | Stomach Neoplasms | 1.16e-03 | 297 | 78 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.21e-03 | 300 | 78 | 5 | C0024623 | |
| Disease | Lymphoma, Follicular | 1.27e-03 | 20 | 78 | 2 | C0024301 | |
| Disease | central corneal thickness | 1.38e-03 | 309 | 78 | 5 | EFO_0005213 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.45e-03 | 84 | 78 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.54e-03 | 22 | 78 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | open-angle glaucoma | 1.67e-03 | 191 | 78 | 4 | EFO_0004190 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.68e-03 | 23 | 78 | 2 | C1708353 | |
| Disease | malignant astrocytoma (is_marker_for) | 1.68e-03 | 23 | 78 | 2 | DOID:3069 (is_marker_for) | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.96e-03 | 335 | 78 | 5 | EFO_0009931 | |
| Disease | obsessive-compulsive disorder, Tourette syndrome | 2.15e-03 | 26 | 78 | 2 | EFO_0004242, EFO_0004895 | |
| Disease | intraocular pressure measurement | 2.30e-03 | 509 | 78 | 6 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLDDHTRCFPNCPFL | 331 | Q13075 | |
| CRCFGEQVTYHNPPL | 491 | P54793 | |
| IQPGVLRCYCPAHDT | 916 | Q9Y6Y1 | |
| YLQFEGPPPICEVHC | 2341 | Q7Z408 | |
| IELFPQSDPACCPVY | 2391 | Q68DQ2 | |
| YRQCGTQRCPEPHEI | 566 | O14514 | |
| CPAICVANTHLLYNP | 301 | Q5VTE6 | |
| HSPVYQTTCCLQPSP | 131 | Q96F81 | |
| CHYATRPPRPQAFCT | 401 | Q5T6C5 | |
| IFNPAHPCELYCRPI | 626 | P58397 | |
| HPCELYCRPIDGQFS | 631 | P58397 | |
| VNPCELHCRPANEYF | 626 | Q9UKP4 | |
| CPVFACIQEFRFQPP | 381 | Q8NCT1 | |
| KPAAYRPCHLQPCNE | 1131 | Q8TE59 | |
| PPSCVLHYYNVPLCV | 451 | Q8WVV9 | |
| LCPQFQNIPAHYSPR | 201 | Q13469 | |
| NQRPAPCYDPCEAVL | 71 | Q8IV08 | |
| HVYNYQPCDHPRQPC | 516 | Q15910 | |
| CAFQPPPSCLRFVQT | 111 | P49771 | |
| CGPNVINHYFCDLVP | 161 | Q8NGF9 | |
| YPNERVCPFPQCRKS | 286 | Q8IX07 | |
| QTSYPLPDPRQFHCI | 121 | Q9H4S2 | |
| LHPACVQLFDSPNPC | 356 | Q8IV20 | |
| QFYPPGCRVTCLDPN | 86 | Q6UX53 | |
| QCGQVHCRLPYTAPP | 326 | Q9UPM6 | |
| CSQYRLPGCPRHFNP | 36 | P20155 | |
| YQCIDTPCPPNYQRD | 5496 | Q96RW7 | |
| LPHPSCEHQFCYPRN | 96 | Q96A11 | |
| GTQPPSVHPCYLRDC | 1661 | Q9P2N4 | |
| CPEYRRQAAQPPHCP | 431 | Q96EP1 | |
| PYPCPTCGTRFRHLQ | 411 | Q8N143 | |
| TFCPMECPPNSHYEL | 1526 | Q9Y6R7 | |
| YRCECPPGHQLSPNI | 1136 | P35555 | |
| FQVHPFYVCSRLPCP | 201 | P36383 | |
| VEPCPHTVDCYISRP | 166 | Q9NTQ9 | |
| ACTPPAEYSPAQRQC | 1061 | Q9NS15 | |
| HVRDCSPPCPNMYFR | 181 | Q9NPG1 | |
| CRNSYHPECLGPNYP | 1501 | Q03164 | |
| PGRYECNCPPDFQLN | 1551 | P35556 | |
| HQDPIYPVCICPAGY | 126 | P82279 | |
| ENLPTRCGFCHIPYD | 456 | Q86YS7 | |
| SIPEQYICYICRDPP | 716 | A8MW92 | |
| PPYCHQRCVNTPGSF | 221 | Q12805 | |
| QDPYILTPENRCVCP | 366 | Q12805 | |
| FFCPQCRALQAPDPT | 56 | Q8IWL3 | |
| EPPRLCYHPIFCGNL | 931 | Q2WGJ9 | |
| YRPHCEPCPAVADLT | 366 | Q8N2Y8 | |
| QSPYAQVPCILLCPQ | 396 | Q7Z572 | |
| ADPCYDPQGRPQFCL | 16 | Q8WTR8 | |
| LPIDPNEPTYCLCNQ | 346 | Q9UK53 | |
| TAEGRPCPYPHCQVL | 751 | Q68DV7 | |
| FQPHCELQPHCELQP | 1281 | Q9P2P6 | |
| MPCHPCPRDYYQPNA | 1121 | Q4LDE5 | |
| PQPEQRPYSCPQLHC | 61 | Q9UPG8 | |
| NCFLSSYPNPVAHLP | 846 | O75153 | |
| YPDIPQFCIPCQLHN | 1281 | Q9BXT8 | |
| QYRHPCAPSVPRYDQ | 261 | Q9H4B6 | |
| NSPRIPCPCQLIEAY | 316 | Q5VZI3 | |
| HCSFSQPVFPYLNPR | 466 | Q9C035 | |
| CQNPFCEPVFVRYPN | 821 | Q8WUH2 | |
| SIVNCLQPHPSYCFL | 581 | Q8N5D0 | |
| HPRVNFCPLPSEQCY | 41 | Q15654 | |
| CIIPRFYVHPDSPCS | 171 | Q9Y458 | |
| HCLRPICFPGYVPNS | 1036 | A6NE52 | |
| ERPYRCPHCADAFPQ | 521 | Q9H9D4 | |
| CVYFVPPTGHCLRPL | 161 | Q8IYM1 | |
| QEALPPPCESEIYCH | 21 | O43280 | |
| EFPPQLRSVCHCLYQ | 1356 | P21359 | |
| QAYCCILQDCFPVHP | 3001 | Q86WI1 | |
| DSSVCPVCQPHPVYR | 701 | Q13472 | |
| PYVCIHCQRQFADPG | 501 | Q13105 | |
| PLCRQFANSVLPCYP | 1361 | Q6ZT12 | |
| CQPYLQDVPRIQHCP | 136 | P0C7W0 | |
| PKDPYCHPVCANRFS | 66 | Q9Y5Q8 | |
| EPNPVPNFIHCRSYL | 1141 | Q92508 | |
| PCLVCNNPEVPFCYI | 3531 | Q5T4S7 | |
| VVHTGQRPYPCPECD | 266 | Q6IV72 | |
| TCPEHYRQPLNVYCL | 96 | Q8IWR1 | |
| PPVPRADQRHGCYVC | 166 | Q96H86 | |
| FYQRQHRLPEPSCPQ | 826 | P29597 | |
| SCPQLRHYFQQPPRC | 1371 | Q9P2D8 | |
| HTGERPYQCPDCPKA | 86 | Q5EBL2 | |
| SIPCRSPGCPRLYHF | 181 | O14686 | |
| GCQYLCLPAPQINPH | 676 | P01130 | |
| VPAPPCNLEEFQCAY | 186 | O75096 |